For what it is worth, a little bird told me that, at the beginning of November, Calimmune was halfway through dosing its second cohort (2 out of 4 patients) and is on track for cohort three to start dosing early in the New Year. If this is true, then we should be looking at some results Q3 2015.
Calimmune
-
- There are more pages in this discussion • 25 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)